A hydrogen sulfide-responsive prodrug for monitoring real-time release and improving therapeutic effects of anticancer drug SN-38
Kunshan Huang, Song Xie, Weijun Wang, Zai‐Sheng Wu, Juhong Wu, Lizhi Jiang, Juanjuan Chen, Jinyu Li
Topics & Concepts
ProdrugIrinotecanSN-38Active metaboliteChemistryDrugPharmacologyCamptothecinIn vitroTherapeutic indexCancer cellToxicityCancer researchCombinatorial chemistryCancerMetaboliteMedicineBiochemistryInternal medicineOrganic chemistryColorectal cancerCancer therapeutics and mechanismsNanoplatforms for cancer theranosticsSynthesis and Biological Evaluation